A
Antonietta Cargnel
Researcher at University of Milan
Publications - 115
Citations - 3414
Antonietta Cargnel is an academic researcher from University of Milan. The author has contributed to research in topics: Pneumocystis carinii & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 30, co-authored 115 publications receiving 3367 citations.
Papers
More filters
Journal ArticleDOI
Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.
Vincent Soriano,Mark S. Sulkowski,Colm Bergin,Angelos Hatzakis,Patrice Cacoub,Christine Katlama,Antonietta Cargnel,Stefan Mauss,Douglas T. Dieterich,Santiago Moreno,C. Ferrari,Thierry Poynard,Jürgen K. Rockstroh +12 more
TL;DR: There are several reasons to highlight HBV in HIV positive individuals, and a few reports have devoted particular attention to hepatitis B, which is currently an important cause of morbidity and mortality among HIV-infected patients in the western world.
Journal ArticleDOI
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.
Vincent Soriano,Massimo Puoti,Mark S. Sulkowski,Antonietta Cargnel,Yves Benhamou,Marion G. Peters,Stefan Mauss,Norbert Bräu,Angelos Hatzakis,Stanislas Pol,Juergen K. Rockstroh +10 more
TL;DR: Eleven areas have been identified in which new recommendations are particu-larly needed: management of patients with persistently normalaminotransferasesliverrosis assessment: when and how predictors of response to anti-HCV therapy in coinfected patients, and interactions between HCV medications and antiretroviraldrugs.
Journal ArticleDOI
Care of patients with hepatitis C and HIV co-infection.
Vincent Soriano,Massimo Puoti,Mark S. Sulkowski,Stefan Mauss,Patrice Cacoub,Antonietta Cargnel,Douglas T. Dieterich,Angelos Hatzakis,J K Rockstroh +8 more
TL;DR: A final consensus was reached in a second meeting of experts in the field of HIV and viral hepatitis in the setting of HIV infection held in Barcelona in the summer of 2002, and is presented here.
Journal ArticleDOI
Update on Pneumocystis carinii f. sp.hominis Typing Based on Nucleotide Sequence Variations in Internal Transcribed Spacer Regions of rRNA Genes
Chao-Hung Lee,Jannik Helweg-Larsen,Xing Tang,Shaoling Jin,Baozheng Li,Marilyn S. Bartlett,Jang Jih Lu,Bettina Lundgren,Jens D Lundgren,Mats Olsson,Sebastian Lucas,Patricia Roux,Antonietta Cargnel,Chiara Atzori,Olga Matos,James W. Smith +15 more
TL;DR: 59 types of P. carinii f.
Journal ArticleDOI
When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study.
A. Cozzi Lepri,Andrew N. Phillips,A d'Arminio Monforte,Francesco Castelli,Andrea Antinori,A. De Luca,Patrizio Pezzotti,F. Alberici,Antonietta Cargnel,Pierfrancesco Grima,R. Piscopo,Tullio Prestileo,G. Scalise,M Vigevani,M. Moroni +14 more
TL;DR: There was no clear immunological or virological advantage in starting HAART at a CD4 cell count > 350 rather than at 200–350 × 106 cells/l, and the increase in CD4 cells restored by HAART is meaningful in that they are associated with reduced risk of disease/death.